ImmunisLogoWImmunisLogocropped-immunislogo.pngcropped-immunislogo.png
  • Home
  • About Us
    • Mission
    • Technology
    • Leadership
  • Resources
    • About secretome biologics
    • About IMM01-STEM
    • About sarcopenia
    • Interested in a clinical trial?
  • Pipeline
    • STEM-MYO Program
      • Phase 1/2a Clinical Trial
    • STEM-META Program
      • Phase 2 Clinical Trial
  • News
    • Awards
    • Media
    • Press Releases
  • Contact
✕

Revolutionizing
Longevity with
Multi-active
Biologics
Immunis is a clinical-stage biotech developing a clinically advanced, first-in-class stem cell-derived secretome product targeting the underlying factors of aging that drive muscle and metabolic disease. IMM01-STEM is an investigational product, a complex biologic comprised of regenerative factors that impact multiple signaling pathways. Immunis is dedicated to maximizing health span and to minimizing disease through the advancement of transformative medicine. Learn More
Muscle -
the Motor
of Longevity
Muscle health is a critical determinant of your quality of life. IMM01-STEM aims to regenerate muscle and enhance muscle function, giving you the strength to maintain independence as you age. Learn more

Recent News

  • Mar 5, 2026

    Immunis Licenses Treatment Candidate for Dyskinesia Associated with Parkinson’s Disease

  • Jan 14, 2026

    Immunis Announces Preliminary Results from First-Ever Phase 2 Study of a Secretome-Based Biologic Showing Improved Gait Speed in Obese Sarcopenic Seniors

  • Nov 20, 2025

    Immunis Named by The Healthcare Technology Report as one of the “Top 50 Healthcare Technology Companies of 2025”

Navigation

  • Home
  • About Us
    • Mission
    • Technology
    • Leadership
  • Resources
    • About secretome biologics
    • About IMM01-STEM
    • About sarcopenia
    • Interested in a clinical trial?
  • Pipeline
    • STEM-MYO Program
      • Phase 1/2a Clinical Trial
    • STEM-META Program
      • Phase 2 Clinical Trial
  • News
    • Awards
    • Media
    • Press Releases
  • Contact

Contact info

Immunis, Inc.
Irvine, California


contact@immunisbiomedical.com

Copyright © 2026 Immunis, Inc.